EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

B Cell Deficiency Protects Against the Development of c‐MET and Beta‐Catenin Driven Hepatocellular Carcinoma in Mice

Fang Wang, Eun Bi Lim, Rehan Mehta, Yee Ling Wu iD

Cell Biology International · 2026-11 · 50 (11)

DOI: 10.1002/cbin.70227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biology International, online erschienen am 17.10.2026. Verfasst von Fang Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, B-Lymphocytes, beta Catenin. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Loyola University Chicago.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC), a lethal form of liver cancer, continues to show rising mortality rates despite advancements in immunotherapies. This highlights the need for more effective treatments. Recent studies linked the presence of B cells within human tumors, including HCC, to improved responses to immunotherapy and better prognoses. Specifically, tumor‐infiltrating B cells have been associated with reduced cancer cell proliferation, suggesting that B cell‐mediated responses may be harnessed as a potential therapeutic strategy against HCC. However, in advanced HCC, IL‐10‐producing regulatory B cells accumulate and promote tumor growth. These paradoxical findings on B cells in human HCC highlight the necessity for clarifying the specific functions of B cells in HCC development to develop B cell‐targeted therapies. To investigate the role of B cells in HCC, we used B cell‐deficient (muMT) mice and anti‐CD20 antibodies to deplete B cells in WT mice. In both systems, we observed a strong protection against liver tumor formation upon HCC induction, indicating the presence of a potent anti‐tumor effect in the absence of B cells before HCC induction. Additionally, depletion of B cells after tumor foci have formed in the liver at later stage of HCC also potently suppressed tumor growth. Functionally, depletion of CD4 + and CD8 + T cells partially restored susceptibility to tumor growth, suggesting that B cell depletion suppresses HCC development partly through enhanced T cell‐mediated immunity. These findings reveal an underappreciated tumor‐suppressing effect of B cells in HCC and suggest that targeting the mechanisms of B cell suppression may boost anti‐tumor responses in HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsB-Lymphocytesbeta CateninAnimalsMiceHumansMice, Inbred C57BLCell Proliferation

Stichwörter der Autor:innen

B cellsCD4CD8hepatocellular carcinomainnate immune cells

Substanzen

beta Catenin

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA.

ORCID-Profile: Yee Ling Wu

Förderung

  • Loyola University Chicago

Zitieren

APA

Wang, F., Lim, E. B., Mehta, R., & Wu, Y. L. (2026). B Cell Deficiency Protects Against the Development of c‐MET and Beta‐Catenin Driven Hepatocellular Carcinoma in Mice. Cell Biology International, 50(11). https://doi.org/10.1002/cbin.70227

Vancouver

Wang F, Lim EB, Mehta R, Wu YL. B Cell Deficiency Protects Against the Development of c‐MET and Beta‐Catenin Driven Hepatocellular Carcinoma in Mice. Cell Biology International. 2026;50(11). doi:10.1002/cbin.70227

BibTeX
@article{Wang2026,
  author = {Wang, Fang and Lim, Eun Bi and Mehta, Rehan and Wu, Yee Ling},
  title = {B Cell Deficiency Protects Against the Development of c‐MET and Beta‐Catenin Driven Hepatocellular Carcinoma in Mice},
  journal = {Cell Biology International},
  year = {2026},
  volume = {50},
  number = {11},
  doi = {10.1002/cbin.70227}
}
Kostenlos starten →